Castle Biosciences (CSTL) Competitors $23.66 +0.07 (+0.30%) Closing price 04:00 PM EasternExtended Trading$23.68 +0.02 (+0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CSTL vs. VCYT, ADUS, CELC, PACS, LFST, NHC, ARDT, PGNY, AVAH, and GRALShould you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include Veracyte (VCYT), Addus HomeCare (ADUS), Celcuity (CELC), PACS Group (PACS), LifeStance Health Group (LFST), National HealthCare (NHC), Ardent Health (ARDT), Progyny (PGNY), Aveanna Healthcare (AVAH), and GRAIL (GRAL). These companies are all part of the "healthcare" industry. Castle Biosciences vs. Its Competitors Veracyte Addus HomeCare Celcuity PACS Group LifeStance Health Group National HealthCare Ardent Health Progyny Aveanna Healthcare GRAIL Veracyte (NASDAQ:VCYT) and Castle Biosciences (NASDAQ:CSTL) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Is VCYT or CSTL more profitable? Veracyte has a net margin of 5.50% compared to Castle Biosciences' net margin of -2.73%. Veracyte's return on equity of 6.07% beat Castle Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Veracyte5.50% 6.07% 5.53% Castle Biosciences -2.73%2.37%2.03% Do analysts recommend VCYT or CSTL? Veracyte currently has a consensus price target of $40.90, suggesting a potential upside of 16.73%. Castle Biosciences has a consensus price target of $37.00, suggesting a potential upside of 56.87%. Given Castle Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Castle Biosciences is more favorable than Veracyte.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 2 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.67Castle Biosciences 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Which has more risk and volatility, VCYT or CSTL? Veracyte has a beta of 2.11, meaning that its share price is 111% more volatile than the S&P 500. Comparatively, Castle Biosciences has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Do institutionals & insiders hold more shares of VCYT or CSTL? 92.6% of Castle Biosciences shares are owned by institutional investors. 1.4% of Veracyte shares are owned by insiders. Comparatively, 6.5% of Castle Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor VCYT or CSTL? In the previous week, Veracyte had 8 more articles in the media than Castle Biosciences. MarketBeat recorded 9 mentions for Veracyte and 1 mentions for Castle Biosciences. Castle Biosciences' average media sentiment score of 0.81 beat Veracyte's score of 0.71 indicating that Castle Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Veracyte Positive Castle Biosciences Positive Which has preferable valuation and earnings, VCYT or CSTL? Veracyte has higher revenue and earnings than Castle Biosciences. Castle Biosciences is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$445.76M6.18$24.14M$0.33106.18Castle Biosciences$332.07M2.06$18.25M-$0.35-67.39 SummaryVeracyte beats Castle Biosciences on 11 of the 16 factors compared between the two stocks. Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CSTL vs. The Competition Export to ExcelMetricCastle BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$684.64M$12.26B$9.05B$10.58BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-67.4321.6485.8427.32Price / Sales2.06275.72535.95201.92Price / Cash23.3047.1237.9261.55Price / Book1.4510.4113.026.76Net Income$18.25M-$52.40M$3.30B$275.79M7 Day Performance6.10%6.34%4.69%2.44%1 Month Performance-4.31%16.09%9.86%8.86%1 Year Performance-17.96%33.38%84.90%35.45% Castle Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CSTLCastle Biosciences2.5934 of 5 stars$23.66+0.3%$37.00+56.4%-21.4%$686.38M$332.07M-67.60540Analyst ForecastVCYTVeracyte3.692 of 5 stars$33.61+0.5%$40.90+21.7%+4.8%$2.63B$445.76M101.85790Analyst UpgradeInsider TradeADUSAddus HomeCare4.987 of 5 stars$117.79+0.4%$138.89+17.9%-11.4%$2.16B$1.15B26.0049,703Analyst ForecastCELCCelcuity2.5639 of 5 stars$52.07+2.9%$56.50+8.5%+224.4%$2.15BN/A-15.0940Analyst ForecastPACSPACS Group2.9827 of 5 stars$13.84-1.0%$31.00+124.1%-66.0%$2.13B$3.11B0.0032,433LFSTLifeStance Health Group3.3641 of 5 stars$5.42flat$8.50+56.8%-17.3%$2.11B$1.32B-108.4010,218News CoverageAnalyst UpgradeNHCNational HealthCareN/A$122.47-3.1%N/A-0.5%$1.96B$1.46B15.3512,400ARDTArdent Health3.9859 of 5 stars$13.23-0.2%$19.33+46.1%-17.0%$1.90B$5.97B7.3124,900Analyst ForecastPGNYProgyny3.8769 of 5 stars$21.42-0.2%$25.44+18.8%+26.1%$1.85B$1.17B36.31310Positive NewsAnalyst ForecastAVAHAveanna Healthcare1.0144 of 5 stars$8.87+1.4%$7.92-10.7%+100.7%$1.83B$2.02B110.8833,500Analyst ForecastGRALGRAIL1.1981 of 5 stars$58.77+17.9%$31.50-46.4%+459.9%$1.80B$125.60M-4.481,360News CoverageAnalyst ForecastInsider TradeHigh Trading Volume Related Companies and Tools Related Companies Veracyte Alternatives Addus HomeCare Alternatives Celcuity Alternatives PACS Group Alternatives LifeStance Health Group Alternatives National HealthCare Alternatives Ardent Health Alternatives Progyny Alternatives Aveanna Healthcare Alternatives GRAIL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CSTL) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
